The June 10 vote is a binary catalyst — approval triggers automatic conversion of Series B Preferred into common, massively increasing float and likely pressuring the stock as holders with beneficial ownership limitations may sell. Monitor the vote outcome and any waiver of beneficial ownership limitations by Series B holders, which would determine the actual number of shares converted. The $200M cash runway provides a floor, but the dilution overhang is significant.
Price Chart
Executive Summary
Sensei Biotherapeutics filed a DEFA14A proxy supplement providing unaudited pro forma financials for the conversion of Series B Preferred Stock into common stock, scheduled for a shareholder vote on June 10, 2026. The conversion would add ~24.4M shares to the float, massively diluting existing common holders (pro forma share count ~25.7M vs 1.3M actual), but the company holds $152.3M cash and $50.5M in marketable securities post-Faeth acquisition and PIPE. The filing is routine proxy solicitation material with no change to board recommendations.
Key Financial Metrics
Key Facts
- Annual Meeting scheduled for June 10, 2026; record date April 13, 2026
- Series B Preferred Stock will automatically convert into ~24.4M shares of common stock three business days after shareholder approval
- Pro forma weighted-average shares outstanding would increase from 1,295,052 to 25,729,972 (19.9x dilution)
- Pro forma net loss per share improves from ($131.45) to ($6.62) due to share count increase
- Company had $152.3M cash and $50.5M marketable securities as of March 31, 2026
- Series B Preferred Stock was issued in connection with the February 2026 acquisition of Faeth Therapeutics and a concurrent $200M PIPE financing
- Board of Directors recommendations on all proposals remain unchanged from the Definitive Proxy Statement
Financial Impact
Conversion of Series B Preferred Stock will add ~24.4M common shares, increasing diluted share count ~19.9x from 1.3M to 25.7M. Net loss per share improves from ($131.45) to ($6.62) on a pro forma basis, purely a mechanical effect of denominator expansion. No change to cash position ($152.3M) or total assets ($205.4M).
Risk Factors
- Massive dilution: ~24.4M new shares entering the float could overwhelm current trading liquidity
- Beneficial ownership limitations may limit conversion, but waivers could increase dilution beyond expectations
- Stockholder approval may fail, preventing conversion and creating uncertainty around Series B terms
- Nasdaq listing application approval is a condition to waiver of beneficial ownership limitations
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-234885 |
| Document: 0001193125-26-234885-index-headers.html | 0001193125-26-234885 |
| Document: 0001193125-26-234885-index.html | 0001193125-26-234885 |
| Document: 0001193125-26-234885.txt | 0001193125-26-234885 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 16, 2026 19w ago | 3 | $13.86 | awaiting T+5 | — | — |
Jun 15, 2026 19w ago | 8-K | $13.04 | awaiting T+5 | — | — |
Jun 15, 2026 19w ago | EFFECT | $13.04 | awaiting T+5 | — | — |
Jun 10, 2026 19w ago | S-3/A | $10.79 $13.85 | ▲ +28.36% | ▲ +27.93% | — |
Jun 10, 2026 19w ago | 8-K | $10.79 $13.85 | ▲ +28.36% | ▲ +27.93% | — |
Jun 2, 2026 21w ago | 10-K/A | $16.10 $12.63 | ▼ −21.53% | ▼ −18.56% | — |
Jun 2, 2026 21w ago | S-3/A | $16.10 $12.63 | ▲ +21.53% | ▲ +18.56% | — |
Jun 1, 2026 21w ago | Insider Cluster | $16.10 $12.63 | ▲ +21.53% | ▲ +18.56% | — |
May 22, 2026 22w ago | DEFA14A | $16.47 $19.79 | ▲ +20.16% | ▲ +19.07% | — |
May 22, 2026 22w ago | 8-K | $16.47 $19.79 | ▲ +20.16% | ▲ +19.07% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers